VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial

VERU-944 Therapy for Hot Flashes in Men Receiving Prostate Cancer Hormone Treatment Heads to Trial
Veru Healthcare is set to begin a Phase 2 clinical trial evaluating VERU-944 (APP-944) for the treatment of hot flashes in men receiving hormone therapy for prostate cancer. The announcement comes after a Pre-Investigational New Drug Application meeting with the U.S. Food and Drug Administration (FDA). “We had a very positive meeting with FDA during which

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *